522 Postmarket Surveillance Studies Database

The FDA has the authority to require device manufacturers to perform postmarket surveillance under Section 522 of the Food, Drugs and Cosmetics (FD&C) Act, when questions are identified for devices that meet the statutory criteria. This database contains information about 522 Postmarket Surveillance Studies that have been required. This database allows you to search information about the postmarket surveillance requirements by manufacturer or device.

Learn more...

To search for Manufacturer beginning with a specific letter, select that letter

A

B

C

D

E

F

G

H

I

J

L

M

N

O

P

R

S

T

U

V

W

X

Z

AE and effectiveness rates

General
Study Status	Terminated
522 Number / Requirement Number	PS120078 / PSS001
Date Original Plan Accepted	01/03/2012
Study Name	AE and effectiveness rates
Device Name	Veritas collagen matrix
Root Document Number	K030879  K062915
General Study Protocol Parameters
Study Design	Retrospective Cohort Study
Data Source	External Registry
Comparison Group	Concurrent Control
Analysis Type	Analytical
Study Population	Adult: >21
Detailed Study Protocol Parameters
Study Objectives	Postmarket surveillance (522) order no longer applies. Indication for Use revised and no longer include the indication subject of the 522 order.

Contact Us

---

Mandated Studies Program
Food and Drug Administration
10903 New Hampshire Ave.
Silver Spring, MD 20993-0002
Email: MandatedStudiesPrograms@fda.hhs.gov

Additional Resources

---

• Postmarket Surveillance Under Section 522 of the Federal Food, Drug, and Cosmetic Act, Guidance for Industry and Food and Drug Administration Staff
• 522 Program Background